Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSL2000026	Durvalumab	durvalumab	Injection	Biological Products	Import Drug Application	2020-03-06		Medimmune LLC	In Review	2020-03-05	view
JXSL1800045	Durvalumab	durvalumab	Injection	Biological Products	Import Drug Application	2018-10-29		Medimmune LLC	In Review	2018-10-27	view
JXSL1900047	Durvalumab	durvalumab	Injection	Biological Products	Import Drug Application	2019-05-15		Medimmune LLC	In Review	2019-05-14	view
JXSL2000047	Durvalumab	durvalumab	Injection	Biological Products	Import Drug Application	2020-05-18		Medimmune LLC	In Review	2020-05-16	view
JXSL1800077	Durvalumab	durvalumab	Injection	Biological Products	Import Drug Application	2019-01-09		Medimmune LLC	In Review	2019-01-08	view
JXSL1800011	Durvalumab	durvalumab	Injection	Biological Products	Import Drug Application	2018-05-02		Medimmune LLC	Certificate Issued	2018-08-14	view
JXSL1900044	Durvalumab	durvalumab	Injection	Biological Products	Import Drug Application	2019-04-25		Medimmune LLC	In Review	2019-04-24	view
JXSL2000019	Durvalumab	durvalumab	Injection	Biological Products	Import Drug Application	2020-02-19	MedImmune LLC	Medimmune LLC	In Review	2020-02-18	view
JXSL1900010	Durvalumab	durvalumab	Injection	Biological Products	Import Drug Application	2019-02-20		Medimmune LLC	In Review	2019-02-19	view
JYSB1900329	Durvalumab	durvalumab	Injection	Biological Products	Supplementary Application	2019-11-30		Medimmune LLC;Cook Pharmica LLC	In Review	2019-11-29	view
JXSL2000134	Durvalumab	durvalumab	Injection	Biological Products(2.2)	Import Drug Application	2020-07-23		Medimmune LLC	In Review	2020-07-22	view
JXSL1700053	Durvalumab	durvalumab	Injection	Biological Products	Import Drug Application	2017-09-13	MedImmune LLC	Medimmune LLC	Certificate Issued	2018-01-23	view
JXSL1800078	Durvalumab	durvalumab	Injection	Biological Products	Import Drug Application	2019-01-09		Medimmune LLC	In Review	2019-01-08	view
JXSL1800062	Durvalumab	durvalumab	Injection	Biological Products	Import Drug Application	2018-12-12		Medimmune LLC	In Review	2018-12-11	view
JXSB2000050	Durvalumab	durvalumab	Injection	Biological Products(2.2)	Supplementary Application	2020-12-21		Medimmune LLC;Catalent Indiana LLC	In Review	2021-05-09	view
JXSL1900086	Durvalumab	durvalumab	Injection	Biological Products	Import Drug Application	2019-09-20		Medimmune LLC	In Review	2019-09-19	view
JXSL1700026	Durvalumab	durvalumab	Injection	Biological Products	Import Drug Application	2017-05-31	MedImmune LLC	Medimmune LLC	Certificate Issued	2017-10-27	view
JXSB2200123	Durvalumab	durvalumab	Injection	Biological Products	Supplementary Application	2022-09-27		Medimmune LLC;Catalent Indiana LLC			view
JXSS1800041	Durvalumab注射液	durvalumab	Injection	Biological Products	Import Drug Application	2018-12-26		Catalent Indiana LLC;Astrazeneca Uk Ltd	Certificate Issued	2019-12-11	view
JXSS1800040	Durvalumab注射液	durvalumab	Injection	Biological Products	Import Drug Application	2018-12-26		Catalent Indiana LLC;Astrazeneca Uk Ltd	Certificate Issued	2019-12-11	view